Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Metsera, Inc. - Common Stock (NQ:MTSR)

63.31 -0.42 (-0.66%)
Streaming Delayed Price Updated: 2:17 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,433,558
Open 64.00
Bid (Size) 63.28 (3)
Ask (Size) 63.33 (1)
Prev. Close 63.73
Today's Range 63.12 - 64.33
52wk Range 12.30 - 66.10
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism. 
Via Stocktwits
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga

Performance

YTD
+138.9%
+138.9%
1 Month
+21.0%
+21.0%
3 Month
+91.9%
+91.9%
6 Month
+171.0%
+171.0%
1 Year
+138.9%
+138.9%

More News

Read More
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Via Investor's Business Daily
Topics Economy Government
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
Via Stocktwits
Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer
Via Stocktwits
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
Via Stocktwits
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
2 High-Yield Stocks With Fresh Catalysts
Via The Motley Fool
Topics Lawsuit
Google Parent Alphabet Has $754 Million Invested in These 3 Hot Growth Stocks. Here's the 1 Wall Street Likes the Most.
Via The Motley Fool
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
Via The Motley Fool
Topics Government Intellectual Property World Trade
HALPER SADEH LLC ENCOURAGES MTSR, HOLX, MRUS SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
From Halper Sadeh LLC
Via GlobeNewswire
Metsera Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR
From Kahn Swick & Foti, LLC
Via Business Wire
2 Mega-Dividend Stocks With Yields As High As 7%
Via The Motley Fool
Topics Economy Government Intellectual Property
Down 44%, Should You Buy the Dip on Viking Therapeutics?
Via The Motley Fool
Where Will Pfizer Be in 5 Years?
Via The Motley Fool
Topics Intellectual Property World Trade
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
From Brodsky & Smith LLC
Via GlobeNewswire
Down 50%, Should You Buy the Dip on Pfizer?
Via The Motley Fool
Topics Intellectual Property
3 Reasons to Buy Pfizer Stock Now
Via The Motley Fool
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
Via The Motley Fool
Topics Intellectual Property
3 Things You Need to Know if You Buy Pfizer Today
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Metsera, Inc. - Common Stock publicly traded?
Yes, Metsera, Inc. - Common Stock is publicly traded.
What exchange does Metsera, Inc. - Common Stock trade on?
Metsera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metsera, Inc. - Common Stock?
The ticker symbol for Metsera, Inc. - Common Stock is MTSR on the Nasdaq Stock Market
What is the current price of Metsera, Inc. - Common Stock?
The current price of Metsera, Inc. - Common Stock is 63.31
When was Metsera, Inc. - Common Stock last traded?
The last trade of Metsera, Inc. - Common Stock was at 10/31/25 02:17 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.